Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2005 1
2006 4
2007 5
2008 4
2009 6
2010 10
2011 12
2012 9
2013 7
2014 8
2015 4
2016 10
2017 12
2018 18
2019 17
2020 7
2021 19
2022 15
2023 11
2024 10
2025 13
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yun jong hee (2 results)?
Autoantibody Biomarkers in Rheumatic Diseases.
Kang EH, Ha YJ, Lee YJ. Kang EH, et al. Among authors: lee yj. Int J Mol Sci. 2020 Feb 18;21(4):1382. doi: 10.3390/ijms21041382. Int J Mol Sci. 2020. PMID: 32085664 Free PMC article. Review.
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial.
Tamai H, Ikeda K, Miyamoto T, Taguchi H, Kuo CF, Shin K, Hirata S, Okano Y, Sato S, Yasuoka H, Kuwana M, Ishii T, Kameda H, Kojima T, Taninaga T, Mori M, Miyagishi H, Sato Y, Tsai WC, Takeuchi T, Kaneko Y; MIRACLE study collaborators. Tamai H, et al. Lancet Rheumatol. 2023 Apr;5(4):e215-e224. doi: 10.1016/S2665-9913(23)00070-X. Lancet Rheumatol. 2023. PMID: 38251524 Clinical Trial.
Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial.
Tamai H, Ikeda K, Miyamoto T, Taguchi H, Kuo CF, Shin K, Hirata S, Okano Y, Sato S, Yasuoka H, Kuwana M, Ishii T, Kameda H, Kojima T, Nishi Y, Mori M, Miyagishi H, Toshima G, Sato Y, Tsai WC, Takeuchi T, Kaneko Y; MIRACLE Study Group. Tamai H, et al. Ann Rheum Dis. 2025 Jan;84(1):41-48. doi: 10.1136/ard-2024-226350. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39874232 Clinical Trial.
Cancer risk in Korean patients with gout.
Oh YJ, Lee YJ, Lee E, Park B, Kwon JW, Heo J, Moon KW. Oh YJ, et al. Among authors: lee yj. Korean J Intern Med. 2022 Mar;37(2):460-467. doi: 10.3904/kjim.2020.259. Epub 2021 Mar 23. Korean J Intern Med. 2022. PMID: 32872748 Free PMC article. Clinical Trial.
ARCO Consensus on the Pathogenesis of Non-traumatic Osteonecrosis of the Femoral Head.
Cui Q, Jo WL, Koo KH, Cheng EY, Drescher W, Goodman SB, Ha YC, Hernigou P, Jones LC, Kim SY, Lee KS, Lee MS, Lee YJ, Mont MA, Sugano N, Taliaferro J, Yamamoto T, Zhao D. Cui Q, et al. Among authors: lee yj. J Korean Med Sci. 2021 Mar 15;36(10):e65. doi: 10.3346/jkms.2021.36.e65. J Korean Med Sci. 2021. PMID: 33724736 Free PMC article. Review.
182 results